SCHEMBL23147334

SCHEMBL23147334

C/C(N)=C(/C(=O)O)C(=O)Nc1ccc(F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ TP53 P04637 1/20 0.48
▸ MAPK10 P53779 1/20 0.48
▸ MAPT P10636 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ KMT2A Q03164 3/20 0.47
▸ POLB P06746 1/20 0.47
▸ RAB9A P51151 6/20 0.46
▸ NPC1 O15118 5/20 0.46
▸ NOS1 P29475 1/20 0.46
▸ NOS2 P35228 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ MITF O75030 1/20 0.44
▸ CA1 P00915 2/20 0.43
▸ CA2 P00918 2/20 0.43
▸ CA7 P43166 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29764757 0.84 MAPT (0.53) ALDH1A1TP53MAPK10MAPTMEN1
SCHEMBL11559445 0.83 NPC1 (0.55) ALDH1A1TP53MAPTMEN1KMT2A
SCHEMBL11559448 0.83 NPC1 (0.55) ALDH1A1TP53MAPTMEN1KMT2A
SCHEMBL12657665 0.79 ALDH1A1 (0.58) ALDH1A1TP53MAPK10MAPTMEN1
SCHEMBL2200065 0.78 PTPN1 (0.61) ALDH1A1MAPTMEN1KMT2ARAB9A
SCHEMBL27856323 0.76 ALDH1A1 (0.69) ALDH1A1TP53MAPK10MAPTMEN1
SCHEMBL21568085 0.75 ALDH1A1 (0.67) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL20438791 0.74 HSD17B10 (0.53) ALDH1A1TP53MAPTKMT2APOLB
SCHEMBL5071228 0.73 RXFP1 (0.62) ALDH1A1MAPTMEN1KMT2APOLB
SCHEMBL30890711 0.72 MAPT (0.58) ALDH1A1MAPTMEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021062245-A1 PYRIDONE COMPOUNDS AND METHODS OF USE IN THE MODULATION OF A PROTEIN KINASE EXELIXIS, INC. (US) 2021-04-01 — — WO disclosed
Send feedback